This study provides an exhaustive analysis of the United States Federal and Delaware State Research and Development tax credit requirements as they apply to the innovation ecosystem of Newark, Delaware. It examines five unique local industry case studies and details the relevant government tax administration guidance and judicial precedents governing these statutory incentives.

Industry Case Studies in the Newark, Delaware Ecosystem

The modern economic landscape of Newark, Delaware, is the result of a profound industrial evolution, transitioning from an agricultural and heavy manufacturing center into a highly specialized, technology-driven knowledge economy. Understanding how and why specific industries developed in Newark is essential to understanding how they utilize federal and state Research and Development (R&D) tax credits. The following five case studies demonstrate the integration of local historical development, technological innovation, and the application of complex tax statutes.

Case Study: Clean Energy and Advanced Manufacturing

The transition of Newark from mid-century heavy manufacturing to advanced clean energy production is most visibly embodied by the Science, Technology and Advanced Research (STAR) Campus. In 1951, the Chrysler Corporation constructed a 3.4 million-square-foot assembly plant on a 272-acre site in Newark, originally designed to produce tanks for the United States Army before transitioning to automotive assembly. For over half a century, this facility anchored the local manufacturing economy. Following the plant’s closure amid broader macroeconomic shifts, the University of Delaware acquired the site to develop the STAR Campus, an innovation district explicitly designed to merge academic research with private industry commercialization.

This specific historical availability of massive, industrially zoned infrastructure, combined with a local workforce historically trained in manufacturing and proximity to elite academic engineering programs, made Newark an ideal location for clean energy pioneers. In 2012, Bloom Energy, a California-based technology company, broke ground on a state-of-the-art manufacturing facility at the STAR Campus. Bloom Energy manufactures “Bloom Boxes,” which utilize revolutionary solid oxide fuel cell technology to convert natural gas or biogas into electricity through an electrochemical reaction, completely bypassing traditional combustion processes. The objective was to create a twenty-first-century manufacturing workforce in a region that had suffered severe industrial job losses.

From a tax perspective, the activities at Bloom Energy’s Newark facility perfectly illustrate the application of the R&D tax credit to advanced manufacturing processes. Under the Internal Revenue Code (IRC) Section 41, the definition of a qualifying “business component” explicitly includes a “process”. While the fundamental electrochemistry of solid oxide fuel cells may be established, scaling that technology to commercial mass production introduces massive technical uncertainties. Engineers in Newark tasked with designing custom automated assembly lines, testing new material tolerances for solid oxide wafers under extreme thermal stress, and developing proprietary quality assurance algorithms are engaging in qualified research.

To satisfy the federal “Process of Experimentation” test, these manufacturing engineers cannot rely on off-the-shelf solutions. They must systematically evaluate alternatives through modeling and trial-and-error to overcome uncertainties regarding cycle times, thermal management, and material degradation. The wages paid to the engineers, floor supervisors, and direct support staff involved in these iterative processes constitute eligible Qualified Research Expenses (QREs). Furthermore, because these engineering and prototyping activities occur physically within the borders of Delaware, the associated QREs are fully apportioned to the state. Under Delaware Code Annotated, Title 30, Chapter 20, Subchapter VIII, the corporation can elect to claim a state credit equal to ten percent of its excess Delaware-based QREs, or fifty percent of its apportioned federal Alternative Simplified Credit (ASC), thereby significantly reducing the cost of capital required to maintain a highly skilled domestic manufacturing workforce in Newark.

Case Study: Financial Technology (FinTech) and Software Engineering

Delaware has long been recognized globally as a premier corporate and financial services haven, with approximately ten percent of the state’s working population employed in the finance sector. Newark has leveraged this macroeconomic advantage by cultivating a highly specialized Financial Technology (FinTech) cluster. This evolution is centered around the FinTech Innovation Hub, a six-story, 100,000-square-foot facility located on the STAR Campus, developed through a partnership between the University of Delaware, Discover Bank, and the Delaware Technology Park (DTP). The facility houses the JPMorgan Chase Innovation Center, which focuses on massive-scale cloud migration, artificial intelligence, and machine learning, alongside non-profit accelerators like the Center for Advancing Financial Equity (CAFE) Fintech Accelerator.

The CAFE accelerator and the associated Growth Stage Incubator specifically target the development of software designed to improve financial access and build wealth equity for low-to-moderate-income (LMI) communities. Startups within this Newark ecosystem are developing sophisticated applications, ranging from blockchain-based stablecoin ledgers to “Agentic AI” software designed for alternative risk assessment.

Software development faces unique and highly stringent legal hurdles under federal tax law, specifically regarding the “Internal Use Software” (IUS) regulations under IRC Section 41. If a Newark financial institution develops software solely for its own internal administrative functions, Treasury Regulations mandate that the software must meet an additional “High Threshold of Innovation” test. This requires the taxpayer to prove that the software is highly innovative, involves significant economic risk, and is not commercially available off-the-shelf. However, software developed by FinTech startups intended to be sold, licensed, or hosted as a service facing third-party customers is evaluated under the standard four-part statutory test.

For software engineers in the FinTech Hub developing new machine learning algorithms to assess creditworthiness using non-traditional LMI data sets, the process of training the models involves significant technical uncertainty. Adjusting neural network weights, managing secure data latency across distributed databases, and resolving complex algorithmic biases require a rigid process of experimentation. The wages paid to these software developers and data scientists represent the primary QREs for these firms. For early-stage FinTech startups operating in Newark with average annual gross receipts under the statutory twenty-million-dollar threshold, Delaware’s Small Business alternative calculation is transformative. By doubling the ASC match to one hundred percent of the apportioned federal credit, and capitalizing on the fully refundable nature of the Delaware credit, the state effectively subsidizes a substantial portion of the startup’s software engineering payroll, providing critical financial runway long before the software generates taxable revenue.

Case Study: Advanced Materials and Chemical Engineering

The development of advanced materials and chemical engineering firms in Newark is inextricably linked to the region’s historical proximity to global chemical conglomerates (such as DuPont) and the robust research infrastructure of the University of Delaware. STF Technologies, a company founded in 2013 by University of Delaware researchers and located in the Delaware Industrial Park in Newark, exemplifies this industrial vertical. The company specializes in the research, formulation, and commercialization of Shear Thickening Fluids (STF)—smart, dynamic materials that remain flexible under normal conditions but harden instantaneously upon high-velocity impact. These non-Newtonian fluid systems are engineered for applications in ballistic body armor, personal protective equipment, and impact-absorbing composites. Additionally, the firm develops highly advanced material characterization instruments, such as high-throughput, high-pressure Small Angle Neutron Scattering (SANS) sample environments, often in collaboration with federal entities.

Chemical formulation and materials science inherently satisfy the federal requirement that research must be “Technological in Nature,” as the work relies entirely on the principles of physical science and engineering. When STF Technologies attempts to formulate a novel shear-thickening fluid that must remain viscous at extreme sub-zero temperatures while simultaneously meeting military-grade ballistic resistance standards, they are confronting direct, severe technical uncertainties. The iterative laboratory testing, the blending of various polymers and concentrated mineral suspensions, and the destructive testing of prototypes constitute a textbook process of experimentation. The raw chemical materials and prototype components consumed or destroyed during these tests are legally classified as qualified supply QREs under federal tax law.

A critical legal nuance for advanced materials companies in Newark is the navigation of the “Funded Research Exclusion” codified in IRC Section 41(d)(4)(H). Companies heavily engaged in fundamental soft matter research frequently utilize federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants from agencies such as the Department of Energy or the National Institutes of Health. If a government contract pays a company to perform research on a strict “time and materials” basis where payment is guaranteed regardless of the research outcome, the Internal Revenue Service considers the research “funded.” In such cases, the taxpayer bears no economic risk, and the expenses are wholly ineligible for the R&D credit. To legally claim the federal and Delaware R&D credits, startups relying on federal grants must meticulously structure their contracts to prove that payment is contingent upon the successful delivery of the technological objectives, thereby retaining the economic risk of failure, and they must demonstrate that they retain substantial rights to the intellectual property developed.

Case Study: Biopharmaceuticals and Life Sciences

Newark’s life sciences and biopharmaceutical sector is heavily anchored by the Ammon Pinizzotto Biopharmaceutical Innovation Center located on the STAR Campus. This facility is dedicated to accelerating the manufacture of life-saving medicines and serves as a hub for biological sciences research, training, and commercialization. The surrounding ecosystem is populated by clinical-stage biopharmaceutical companies, such as Prelude Therapeutics, which focuses on the design and development of novel, orally bioavailable, small-molecule therapies targeting key drivers of cancer cell growth, survival, and treatment resistance. The growth of this industry in Newark is supported by a sixty-four percent increase in life sciences degrees awarded in Delaware since 2010, feeding a highly specialized workforce pipeline directly into these advanced laboratories.

In the biopharmaceutical industry, the strategic utilization of the R&D tax credit is of paramount importance to corporate survival. The development of a single novel small-molecule therapy requires years of biological hypothesis generation, complex chemical synthesis, and highly regulated, multi-phase clinical trials. The wages paid to molecular biologists, clinical trial coordinators, computational chemists, and biometric data analysts, along with the immense financial cost of specialized laboratory supplies, reagents, and test compounds, represent massive QREs. The statutory “Process of Experimentation” test is virtually synonymous with the United States Food and Drug Administration (FDA) drug approval process. Biopharmaceutical firms hypothesize molecular binding targets, synthesize thousands of structural compound variations to evaluate alternatives, and meticulously test them in vitro and in vivo to systematically eliminate technical uncertainty regarding efficacy and toxicity.

The strategic application of the Delaware state tax credit provides a critical lifeline to this specific sector. Biotech companies routinely consume tens of millions of dollars in venture capital for up to a decade before achieving commercial viability or generating any taxable revenue. Under historical Delaware tax law, a non-refundable credit was of no immediate use to a company operating at a net operating loss. However, following the legislative elimination of the expenditure cap and the introduction of full refundability, an early-stage biopharma company in Newark can capture its immense QREs, apply the Small Business alternative calculation to maximize the rate, and receive a direct, multi-million dollar cash refund from the Delaware Division of Revenue. This mechanism acts as a critical non-dilutive capital injection, extending the startup’s operational runway and mitigating the extraordinary financial risk of clinical failure inherent in drug development.

Case Study: Agricultural Technology (AgTech) and Sustainable Food Systems

While Newark has evolved into a highly sophisticated technological and financial hub, its roots remain deeply embedded in agriculture. Prior to industrialization, farming was critical to the survival and economic prosperity of the region. Today, the University of Delaware maintains this legacy while pushing it into the future through the College of Agriculture and Natural Resources, which operates a 350-acre working farm and scientific research facility directly on the main campus in Newark. This unique geographical and academic asset provides a sprawling outdoor laboratory encompassing wetlands, greenhouses, and specialized facilities like the Food Sensory, Characterization, and Novel Processing Center, and the Biochar Service Center.

A leading example of private-public Agricultural Technology (AgTech) innovation in Newark is the partnership between SolAgra and the University of Delaware. SolAgra is pioneering research in “agrivoltaics”—the strategic co-location of solar tracking arrays directly over active crop production. The company is constructing highly specialized test arrays over high-value crops, such as tomatoes and strawberries, to evaluate how dual-use agricultural land can simultaneously generate commercial green electricity while actually improving crop quality by mitigating the harsh effects of extreme, climate-change-driven weather conditions.

Agricultural research faces intense scrutiny from federal tax auditors regarding the “Commercial Production” exclusion codified under IRC Section 41(d)(4)(A). If a farming operation is simply cultivating crops for sale using standard, well-established agronomic practices, the costs incurred are standard business deductions, not QREs. To qualify for the R&D credit, an AgTech firm like SolAgra must definitively prove that their activities transcend routine farming and are fundamentally experimental. The engineering design of the patented solar tracking systems, the complex mathematical modeling of shadow patterns, the structural engineering required to safely elevate the arrays over heavy farming equipment, and the systematic collection of data on crop yields under variable artificial sunlight conditions all meet the rigorous criteria of discovering technological information to resolve engineering and biological uncertainty. The R&D claim must meticulously segregate the costs of routine harvesting from the costs of the experiment. The wages of the electrical engineers designing the tracking algorithms, the agronomists analyzing soil moisture differentials under the arrays, and the physical costs of the prototype solar structures qualify as QREs. By locating this research at the Newark test site, the expenses are eligible for the Delaware Small Business computation, providing a vital financial buffer against the risk that the experimental shadow arrays might fail or inadvertently destroy the yield of the test crops.

Detailed Analysis of the United States Federal R&D Tax Credit Framework

The bedrock of technological innovation incentives in the United States is Section 41 of the Internal Revenue Code. The federal R&D tax credit was strategically designed by the United States Congress to stimulate domestic technological innovation, mitigate the inherent financial risks of experimental research, and ensure the United States remains highly competitive in the global macroeconomic landscape. Under IRC Section 41, the credit is generally calculated as twenty percent of a taxpayer’s excess qualified research expenses for the taxable year over a historically determined base amount.

Qualified research expenses primarily consist of in-house research expenses—which include the wages paid to employees directly performing, supervising, or directly supporting qualified research, as well as the cost of tangible supplies consumed or destroyed during the research process—and contract research expenses, which represent payments made to third parties conducting qualified research on the taxpayer’s behalf. However, identifying an expense is only the first procedural step. To legally qualify for the credit, the underlying activities associated with those expenses must survive rigorous scrutiny under the statutory “Four-Part Test”.

The Statutory Four-Part Test

The Internal Revenue Service (IRS) Audit Techniques Guide dictates that in order for an activity to qualify for the research credit, the taxpayer bears the burden of proof to demonstrate that the activity satisfies all four distinct criteria established in IRC Section 41(d). Furthermore, these tests must be applied separately to each specific “business component” of the taxpayer.

The requirement that research must seek to eliminate “technical uncertainty” is the cornerstone of the Section 174 test. Uncertainty exists if the information available to the taxpayer does not establish the capability or method for developing or improving the business component, or the appropriate design of the business component. The “Discovering Technological Information” test explicitly excludes research based on the social sciences, arts, or humanities. Furthermore, the requirement that “substantially all” activities constitute a process of experimentation means that a taxpayer cannot simply claim an entire project if only a small fraction of the time was spent resolving technical issues. The IRS requires meticulous time tracking to ensure that at least eighty percent of the claimed activities were experimental in nature.

Statutory Exclusions to Qualified Research

Even if a specific engineering or scientific activity successfully meets all criteria of the Four-Part Test, it may still be completely disqualified if it falls under one of the specific statutory exclusions explicitly outlined in IRC Section 41(d)(4). The United States Congress implemented these exclusions to prevent taxpayers from claiming subsidies for routine business operations or activities that do not advance the domestic technological baseline.

Key exclusions highly relevant to technology and manufacturing firms include:

• Research After Commercial Production: Any research conducted after the beginning of commercial production of the business component is excluded. Once a product meets its basic functional and economic requirements and is ready for commercial sale, further routine quality control testing or cosmetic modifications do not qualify.
• Adaptation of Existing Business Components: Any research related to the adaptation of an existing business component to a particular customer’s specific requirement or need is excluded. If a software firm simply configures existing code to interface with a new client’s database without changing the underlying architecture, the activity is disqualified.
• Duplication: Research related to the reproduction of an existing business component (reverse engineering) from a physical examination, plans, blueprints, or detailed specifications is not qualified.
• Foreign Research: Any research conducted outside the United States, the Commonwealth of Puerto Rico, or any possession of the United States is excluded. This underscores the legislative intent to retain high-tech jobs domestically.
• Funded Research: Any research funded by any grant, contract, or otherwise by another person or governmental entity is excluded. As discussed in the STF Technologies case study, if the taxpayer does not bear the economic risk of failure, the government will not provide a secondary subsidy through the tax code.

Federal Case Law and Judicial Precedent

The strict statutory language of IRC Section 41 is heavily interpreted and shaped by federal case law. When the Internal Revenue Service audits a taxpayer and disallows an R&D claim, the resulting litigation in the United States Tax Court establishes binding precedents that define the precise boundaries of what constitutes legitimate experimental research versus routine engineering or construction.

In the pivotal May 2023 decision involving Harper, the U.S. Tax Court evaluated a case where the IRS aggressively denied the R&D credits of a design-builder and general contractor. The IRS asserted that the construction firm did not possess a valid “business component,” arguing that designing buildings was routine architecture, not technological research. The Tax Court decisively rejected the IRS’s arguments, ruling that by designing highly complex, bespoke buildings and structures, the taxpayer was indeed conducting research that satisfied the business component test. The court’s opinion officially validated the technical work product of architectural and engineering design firms as the exact type of technical activity Congress sought to encourage, establishing them as excellent candidates for the credit.

However, the judicial system demands rigorous proof of experimentation. In Little Sandy Coal Company, Inc. v. Commissioner, the Tax Court evaluated the R&D claims of a shipbuilding subsidiary. The court meticulously analyzed the “process of experimentation” test and the “substantially all” rule. The court ultimately disallowed the taxpayer’s credit because the company failed to adequately document and prove that eighty percent or more of the claimed activities—specifically including the time spent on direct supervision and direct support activities—were genuinely dedicated to a rigorous process of experimentation rather than routine vessel construction. This case serves as a severe warning to advanced manufacturing firms in Newark that failing to contemporaneously track the exact hours spent testing versus building will result in total disallowance upon audit.

The necessity of demonstrating true technical uncertainty was further highlighted in cases involving engineering firms, such as Phoenix Design and Smith. The Tax Court noted that basic calculations based on readily available data do not constitute an investigative experimental activity if the taxpayer’s engineers already possess the requisite information necessary to address the unknown. The court ruled that performing standard, iterative engineering calculations and emailing the results to an architect is not an evaluative process that mirrors the scientific method. Therefore, Newark engineering firms must explicitly document the specific information that was unavailable at the start of a project and detail the rigorous modeling or physical testing required to discover it.

Detailed Analysis of the Delaware State R&D Tax Credit Regime

To supplement the federal incentives and aggressively compete for high-technology corporate headquarters, the State of Delaware offers a highly robust, taxpayer-friendly state-level R&D tax credit. Governed by Delaware Code Annotated, Title 30, Chapter 20, Subchapter VIII (Sections 2070-2075), the Delaware credit is fundamentally intertwined with the federal framework. The state statutes mandate that any term used generally carries the same meaning as used in the Internal Revenue Code, meaning that any activity conducted within the state borders that meets the federal IRC Section 41 definitions automatically qualifies for the Delaware state credit.

Credit Calculation Methods and Apportionment

Delaware allows corporate taxpayers to make an annual election between two primary calculation methods. Crucially, this election is completely independent of the methodology the taxpayer chooses to utilize on their federal tax return, allowing for maximum state-level optimization.

The first option is Method A, often referred to as the Regular Credit. Under this method, the taxpayer calculates the credit as ten percent of the excess of the taxpayer’s total Delaware qualified research and development expenses for the current taxable year over the taxpayer’s historical Delaware base amount. The Delaware base amount is computed by determining a fixed-base percentage (the ratio of Delaware QREs to Delaware gross receipts for the four preceding years) and multiplying that percentage by the average annual Delaware gross receipts for the four years immediately preceding the credit year.

The second option is Method B, based on the Alternative Simplified Credit (ASC). Under this method, the credit is calculated as fifty percent of Delaware’s apportioned share of the taxpayer’s federal research and development tax credit, calculated using the federal ASC methodology under IRC Section 41(c) using federal definitions. Delaware’s specific “apportioned share” is strictly determined by taking the total amount of the federal ASC the taxpayer claims and multiplying it by an apportionment ratio. This ratio is the taxpayer’s Delaware qualified research and development expenses for the taxable year divided by the taxpayer’s total global qualified research and development expenses for that same year. This apportionment fraction strictly enforces the legislative intent to reward companies based precisely on the volume of research they physically conduct within Delaware’s borders.

The Small Business Alternative Calculation

One of the most aggressive and highly effective legislative mechanisms Delaware utilizes to foster the growth of early-stage startups—particularly in sectors like FinTech and biopharmaceuticals concentrated in Newark—is the Small Business Alternative Calculation. Under Title 30 Section 2070(a), a “small business” is legally defined as any taxpayer with average annual gross receipts (as determined by IRC Section 41) that do not exceed a statutory threshold of twenty million dollars.

For qualifying small businesses, the standard calculation rates are dramatically doubled. If a startup utilizes Method A, the rate is increased from ten percent to twenty percent of the excess Delaware QREs. If the startup elects Method B, the rate is increased from fifty percent to one hundred percent of Delaware’s apportioned share of the federal ASC. Taxpayers making use of this alternative calculation must conform strictly to the twenty-million-dollar average gross receipts definition, regardless of the method by which they calculate their federal credit.

The Commitment to Innovation Act: Refundability and Uncapped Expenditures

The modern utility of the Delaware R&D tax credit was fundamentally reshaped by the passage of the Commitment to Innovation Act, signed into law by Governor Jack Markell in March 2016. Historically, the State of Delaware severely limited the total annual pool of approved R&D credits to an aggregate cap of five million dollars. If the total applications exceeded this cap, the Delaware Division of Revenue was forced to prorate the credits, allocating a fractional mathematical product to each eligible applicant, thereby diluting the incentive’s financial impact. Furthermore, under prior law, the credit was strictly non-refundable; it could only be applied against a taxpayer’s active Delaware corporate income tax liability. For pre-revenue biopharmaceutical startups or early-stage software developers in Newark operating at massive net operating losses, a non-refundable tax credit held zero immediate liquidity value.

The Commitment to Innovation Act radically transformed this landscape. Effective January 1, 2017, the five-million-dollar expenditure cap was entirely eliminated, guaranteeing that companies receive one hundred percent of their calculated and approved credit amount. More importantly, the legislation rendered the tax credit fully refundable. If a taxpayer’s approved research and development tax credit exceeds their qualified tax liability for the taxable year, the Delaware Division of Revenue is legally obligated to pay the unused credit to the taxpayer in the nature of a direct cash tax refund. According to industry analysis, Delaware currently stands as the only state in the country that combines a zero-expenditure cap with a fully refundable tax credit mechanism, creating an incredibly aggressive economic magnet for advanced R&D operations.

Administrative Procedures and Audit Governance

To legally secure the Delaware R&D tax credit, taxpayers are subjected to strict administrative compliance procedures managed by the Delaware Division of Revenue. Eligibility requires that the business actively conduct qualified research activities within the state borders, and the business must proactively apply for annual approval.

Qualified taxpayers must submit a formal application to the Division of Revenue on or before September 15th of the calendar year following the end of the taxable year during which the qualified R&D expenses were incurred. This requires the meticulous completion and filing of Delaware Form 2070AC (or Form 2071AC depending on the entity structure and year), which explicitly details the calculation methods and requires the attachment of the corresponding federal Form 6765.

Once the application is formally approved by the Delaware Division of Revenue, the authorized credit amount listed on Form 2070AC must be transferred to the appropriate line on Delaware Form 700 (Delaware Income Tax Credit Schedule). Both Form 700 and the approved Form 2070AC must then be attached to the entity’s annual corporate income tax return. For pass-through entities such as S-Corporations, Partnerships, or Limited Liability Companies, the approved credit amount is multiplied by the percentage of stock or ownership held by each shareholder or partner, and the resulting proportional credit is passed through to the individual owners via Schedule K-1 allocations.

While the Delaware Division of Revenue does not publish extensive public audit manuals or procedural guidelines specific to the R&D credit, it relies heavily on federal IRS documentation standards. The Director of Revenue possesses broad statutory authority to prescribe the standards for what constitutes “Delaware qualified research and development expenses,” taking into explicit consideration the physical location where the services are performed. Furthermore, the Division of Revenue issues Technical Information Memorandums (TIMs) to guide taxpayers on evolving compliance issues and filing extensions, ensuring the state tax code adapts to broader economic disruptions. Taxpayers in Newark must maintain robust contemporaneous documentation—including project charters, engineering iteration logs, payroll records, and vendor invoices—to substantiate their claims against both federal and state audits. A taxpayer’s eligibility for the Delaware credit remains legally protected and active even in the event that the federal research and development tax credit under IRC Section 41 is temporarily terminated or revoked by the United States Congress, ensuring long-term fiscal stability for local innovation initiatives.

Final Thoughts

The transformation of Newark, Delaware, from a traditional manufacturing center into a highly advanced, multi-disciplinary innovation hub is a testament to the powerful synergy between academic infrastructure and strategic tax policy. The presence of the University of Delaware’s STAR Campus provides the physical and intellectual foundation, but it is the aggressive application of the United States Federal and Delaware State Research and Development tax credits that provides the necessary financial acceleration.

By deeply understanding the rigorous statutory requirements of the federal Four-Part Test, and meticulously navigating complex exclusions such as those governing internal use software and federally funded grants, corporations operating in Newark are able to massively subsidize the inherent financial risks of experimental engineering. Furthermore, the State of Delaware’s unprecedented legislative decision to offer an uncapped, fully refundable tax credit that doubles in value for small businesses creates an unparalleled economic environment. From the advanced solid oxide fuel cells manufactured by Bloom Energy to the proprietary life-saving molecules synthesized at the Ammon Pinizzotto Biopharmaceutical Innovation Center, these localized case studies demonstrate that the strategic monetization of R&D tax credits is not merely an accounting exercise, but a fundamental driver of technological advancement and regional economic dominance.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.